HBK Investments’s Bristol-Myers Squibb BMY Stock Holding History

HBK Investments’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-13,700	Closed	-$876K	–	257
2023 Q2	$876K	Sell	13,700 -266,100	-95%	-$17.8M	﹤0.01%	282
2023 Q1	$19.4M	Buy	+279,800	New	+$19.7M	0.12%	48
2022 Q4	–	Sell	-73,800	Closed	-$5.25M	–	41
2022 Q3	$5.25M	Buy	73,800 +44,600	+153%	+$3.24M	0.04%	186
2022 Q2	$2.25M	Buy	+29,200	New	+$2.22M	0.01%	341
2021 Q3	–	Sell	-74,000	Closed	-$4.95M	–	770
2021 Q2	$4.95M	Buy	74,000 +4,000	+6%	+$261K	0.02%	293
2021 Q1	$4.42M	Sell	70,000 -25,700	-27%	-$1.6M	0.02%	292
2020 Q4	$5.94M	Sell	95,700 -127,200	-57%	-$7.82M	0.04%	240
2020 Q3	$13.4M	Buy	222,900 +100,100	+82%	+$6.02M	0.1%	88
2020 Q2	$7.22M	Buy	+122,800	New	+$7.35M	0.09%	129
2020 Q1	–	Sell	-151,700	Closed	-$9.74M	–	95
2019 Q4	$9.74M	Buy	151,700 +38,800	+34%	+$2.22M	0.09%	125
2019 Q3	$5.72M	Hold	112,900	–	–	0.07%	222
2019 Q2	$5.12M	Sell	112,900 -958,100	-89%	-$44.6M	0.04%	230
2019 Q1	$51.1M	Buy	+1,071,000	New	+$53.4M	0.52%	23

Other funds holding BMY

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

HBK Investments's BMY Position: Q3 2023 in Review

HBK Investments sold out of Bristol-Myers Squibb (BMY) in Q3 2023, closing a stake of 9,760 shares — an estimated $624K sold.

HBK Investments first reported a position in BMY in Q2 2014 and held it in 16 quarters. The position peaked at $38.4M in Q2 2018. 2,387 funds tracked by Wall St. Rank hold BMY as of Q3 2023.

HBK Investments reported no remaining Bristol-Myers Squibb position as of Q3 2023 after selling out during the quarter.
HBK Investments sold 9,760 Bristol-Myers Squibb shares in Q3 2023, an estimated $624K.
HBK Investments first reported a position in Bristol-Myers Squibb in Q2 2014 and held it in 16 quarters.
HBK Investments's Bristol-Myers Squibb position peaked at $38.4M in Q2 2018.
2,387 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q3 2023.

Based on HBK Investments's 13F filing for Q3 2023, filed 14 Nov 2023.